Optum Ventures

Optum Ventures provides capital and strategic guidance to startup companies solving health care's pressing challenges. It is the venture capital investment arm of Optum that invests in digital health companies that use data and insights to help improve consumers' access to health care services and how care is delivered and paid for, and that makes the health care system more reliable and easier to navigate.

Eliza Loring

Vice President

73 past transactions

Medallion

Series C in 2022
Medallion provides a network management platform for the healthcare industry. Its all-in-one licensing, credentialing, and payer enrollment platform gets rid of the logistical headaches that all too often eat up valuable time and energy. The company was founded in 2020 by Derek Lo and is headquartered in San Francisco, California, United States.

Greater Good Health

Series A in 2022
Greater Good Health is a healthcare organization enabling and expanding access to value-based, holistic primary care. Through an innovative Nurse Practitioner-led model, Greater Good Health partners with health plans to build primary care practices in underserved, often rural, communities, and partners with risk-bearing organizations to deploy private-labeled clinical programs that enable the shift to value-based, outcomes-focused care. Greater Good Health's proven care model and clinical programs benefit patients, providers, and payers alike, improving outcomes, reducing costs, and delivering a best-in-class patient experience.

Loop

Series B in 2022
By using data, technology, and high quality medical expertise, we aim to deliver an empathetic people-centric healthcare experience that helps people live longer.

DUOS

Series A in 2022
DUOS is a technology-enabled service provider connecting Medicare beneficiaries to the resources needed to attain the highest level of health. Our proactive and personalized activation platform engages your membership throughout their health journey, delivering quality health outcomes and improving member satisfaction for our valued partners. Our underlying technology aggregates historically siloed data and resources from across the ecosystem, removing barriers to health literacy and access to care, and facilitating contextual and timely connections with closed loop visibility.

Brightline

Series C in 2022
Brightline is a technology-enabled behavioral health home for children and their families. Brightline delivers integrated care through innovative technology, virtual behavioral health services, and a collaborative care team focused on supporting children across developmental stages and their families. The company was founded in 2019 and is based in Palo Alto, California.

Vira Health

Series A in 2022
Vira is a digital health company focused on improving long-term health for women. We do this by addressing female-specific conditions and improving the collection and use of female data in healthcare.

Flume Health

Series A in 2022
Flume Health makes self-insured health plans affordable and easy to use. They do this by combining the incredible best customer support that they would never expect from their health plan administrator, along with a new payments technology that allows its members to see the same providers for 20-40% less than traditional network rates. The company was founded in 2018 and is headquartered in New York.

Scipher Medicine

Series D in 2022
Scipher Medicine develops a healthcare platform designed to determine which drug will work best for each patient. The company is committed to transforming the way providers prescribe drugs, as well as the way manufacturers, develop new drugs. They are building a molecular map of all protein interactions that identifies genomic signatures and links those to disease and predictive treatment outcomes. Using a simple blood sample to analyze RNA, Scipher Medicine can predict if a patient is likely to respond to a targeted therapy before therapy is prescribed. This insight allows patients to start the most effective therapy from day one. For its first commercial product, they have developed PrismRA®, a first-of-its-kind blood test that can predict which patients with rheumatoid arthritis are less likely to respond to TNFi therapies such as Humira® and Enbrel® so that such patients can go on alternative approved drugs. Scipher Medicine is building the future of patient treatment. Most patients who are prescribed blockbuster therapies today don't respond to treatment, costing the healthcare industry billions in wasted drugs while patients continue to suffer. Scipher's platform identifies which drug will work based on the patient's fundamental disease biology, and not based on symptoms, disease classification, or medical bias. A routine blood test predicts which drug he/she will respond to, with our first product focusing on rheumatoid arthritis, ensuring that the most optimal treatment is prescribed from day one. The molecular data generated by our tests are then used to fuel novel target discovery to address a clear unmet medical need in patients who do not respond to any existing therapy.

Secureframe

Series B in 2022
Secureframe empowers businesses to build trust with customers by automating information security and compliance. Thousands of fast-growing businesses such as AngelList, Ramp, Remote, and Coda, trust Secureframe to simplify and expedite their compliance journey for global security and privacy standards such as SOC 2, ISO 27001, PCI DSS, HIPAA, GDPR, and more.

Somatus

Series E in 2022
Somatus is a healthcare company that partners with health plans, health systems, nephrology, and primary care groups. It provides integrated care for patients with or at risk of developing kidney disease. Somatus' vertically integrated clinical services and technology delay or prevent disease progression, improve quality and care coordination, and increase the use of home dialysis modalities and rates of kidney transplantation. The company is headquartered in McLean, Virginia and is founded by a team of healthcare operators, entrepreneurs, and clinicians who treat kidney disease.

Equip Health

Series B in 2022
Equip is a virtual program helping families recover from eating disorders at home with comprehensive, gold-standard care created by experts in the field and people in recovery. Equip’s five-person care teams include dieticians, physicians, therapists, and mentors who deliver wrap-around support to provide families progress and lasting recovery. Kristina Saffran and Erin Parks co-founded the company in San Diego, California in 2019.

Future

Series C in 2022
Future offers one-on-one digital training with fitness coaches, at home, at the gym, or on-the-go. Future pairs its clients with coaches who have trained pro athletes, Hollywood celebrities, and working professionals.

mPulse Mobile

Venture Round in 2022
MPulse Mobile specializes in conversational AI and digital engagement solutions for the healthcare industry. The company combines technology, analytics, and industry expertise that helps healthcare organizations activate their customers to adopt healthy behaviors.

Garner Health

Series B in 2021
Garner Health is a provider of healthcare services used to help employers give their employees a better healthcare experience. The company offers its solution through employers who want to give their employees a better quality healthcare experience and in-turn save on the cost of healthcare because the best doctors end up costing the least money. Garner Health was founded in 2019 and is headquartered in New York.

Holmusk

Venture Round in 2021
Holmusk develops a real-world evidence platform in behavioral health and chronic diseases to expand data-driven, evidence-based care for people managing behavioral health conditions. It works by bringing together specialty behavioral health data and Holmusk’s novel analytics platform to deliver evidence-based insight that can be used to make treatment decisions, as well as the commercialization of new drugs.

Medallion

Series B in 2021
Medallion provides a network management platform for the healthcare industry. Its all-in-one licensing, credentialing, and payer enrollment platform gets rid of the logistical headaches that all too often eat up valuable time and energy. The company was founded in 2020 by Derek Lo and is headquartered in San Francisco, California, United States.

Caresyntax

Series C in 2021
Caresyntax is a digital surgery platform that enables OR teams to predict and improve surgical performance. Its enterprise-grade digital surgery platform delivers insights to improve patient outcomes by using proprietary software and AI to analyze large volumes of video, audio, images, device data, clinical, and operational data in and around the OR. Caresyntax insights help surgeons benchmark and improve their care, hospital administrators use surgical resources more efficiently, medical device companies advance better products, and insurance companies understand risk and devise more tailored policies. The software is used in more than 4,000 operating rooms worldwide, has supported more than 30,000 surgeons, and improved care for more than 2 million patients.

Alma

Series C in 2021
Alma is a membership-based network for mental health care providers that aims to improve access to high-quality, affordable mental health care. Its platform enables providers to accept insurance and also provides a member directory, client-matching service, scheduling, and billing functions, as well as education, training, and a community for support.

Calibrate

Series B in 2021
Calibrate is a digital metabolic health business that provides a virtual program for weight loss. It is creating a new category by improving metabolic health to drive long-term, sustainable weight loss with a program designed by world leaders in obesity and nutrition science. Calibrate combines FDA-approved metabolic medication with a holistic curriculum and 1:1 virtual coaching sessions that drive lasting behavior change. The company was founded in 2020 and is headquartered in New York.

Ultromics

Series B in 2021
They are building world-class diagnostic aids to help cardiologists — powered by artificial intelligence. To date, they have developed the world’s most accurate echocardiography software to improve the diagnosis of coronary heart disease by more than 90%.

Rey

Series A in 2021
Rey is a membership-based, on-demand mental health company on a mission to revolutionize mental health and wellness by improving access to personalized services through technology.

Brightline

Series B in 2021
Brightline is a technology-enabled behavioral health home for children and their families. Brightline delivers integrated care through innovative technology, virtual behavioral health services, and a collaborative care team focused on supporting children across developmental stages and their families. The company was founded in 2019 and is based in Palo Alto, California.

LetsGetChecked

Series D in 2021
LetsGetChecked is an at-home health testing platform that connects customers to regulated laboratory testing to better manage and control one's individual health. LetsGetChecked is making healthcare and diagnostics open and patient-led, empowering people to use technology in a simple yet powerful way. This offers consumers greater control over their individual health. LetsGetChecked is headquartered in New York, New York, with tests covering general wellness, sexual health, women's health, and men's health, and is available nationwide, as well as in Canada and Europe.

Medallion

Series A in 2021
Medallion provides a network management platform for the healthcare industry. Its all-in-one licensing, credentialing, and payer enrollment platform gets rid of the logistical headaches that all too often eat up valuable time and energy. The company was founded in 2020 by Derek Lo and is headquartered in San Francisco, California, United States.

Main Street Health

Series A in 2021
Main Street Health is a provider of value-based, care-focused healthcare services aimed at addressing rural wellness concerns. The company's healthcare services are data-driven, and it provides partner clinics with employees, technology, critical access hospitals, community health centers, and possibilities to flourish in the care delivery model, allowing rural residents to receive the high-quality treatment they need.

Heartbeat Health

Series B in 2021
Heartbeat Health is a healthcare technology company that delivers virtual-first cardiovascular disease prevention and management. Through its data-powered platform and clinical services, the company helps patients and at-risk organizations benefit from higher-value care by reducing cardiovascular risk and the likelihood of future adverse events. It offers tools and resources critical to supporting digital care by virtually connect patients with doctors securely and helps in sharing information in real-time, and collaborate on treatment and diet consultation, and helps patients to keep track of their heart health and be in touch with a cardiologist.

Groups Recover Together

Series C in 2021
Groups Recover Together was founded to make treatment for opioid addiction respectful, accessible, and affordable. We empower our members to regain control of their lives through a proven, evidence-based model of medication-assisted treatment (MAT) with buprenorphine and weekly group therapy.

Vim

Series B in 2021
Founded in 2015, Vim connects data to workflow at health care’s “last mile”: within clinical operations at the point of patient care. Health plans, patients, and medical providers of every size – from independent practitioners to integrated delivery systems – use Vim software to connect data and care across the health system. Vim’s mission is to power affordable, high quality health care through seamless connectivity. For more information, please visit getvim.com.

Kaia Health

Series C in 2021
Kaia Health is a digital therapeutics company that creates evidence-based treatments for a range of disorders including back pain and COPD. Working with experts in various medical fields, the company uses machine learning to deliver individualized app interventions that aim to empower and motivate patients to take control and self-manage their condition with digital alternatives from their home using devices they already own (i.e. smartphones and tablets). The company has enrolled more than 400,000 users to date in its digital therapy program. It was founded in 2016 and is headquartered in Brooklyn, New York.

Vesta Healthcare

Venture Round in 2021
Vesta Healthcare is an industry-leading technology and clinical services organization, dedicated to connecting caregiver insights to the rest of the care team. Vesta Healthcare proactively identifies the need for additional resources in the home and provides 24/7 telehealth support for caregivers and care recipients, with a focus on high-need, frail senior populations. Vesta partners with home care agencies, health plans and providers to create value-based population health programs that emphasize clinical quality, improved health outcomes and personalized engagement. Vesta Healthcare is headquartered in New York, NY.

Unite Us

Series C in 2021
Unite Us is a veteran-led technology company that builds coordinated care networks connecting health and social service providers together. The company helps systems and communities efficiently deliver care and services by inter-connecting providers across communities, seamlessly integrating the social determinants of health into patient care. Providers across the continuum and community are able to externally refer and track every patient’s total health journey while reporting on all tangible outcomes across a full range of services in a centralized, cohesive, and collaborative ecosystem. This social infrastructure helps communities move beyond legacy resource directories, and transform their ability to measure impact, improved health, and outcomes at scale. The company was founded in 2013 by military veterans Dan Brillman and Taylor Justice in New York, New York.

Equip Health

Series A in 2021
Equip is a virtual program helping families recover from eating disorders at home with comprehensive, gold-standard care created by experts in the field and people in recovery. Equip’s five-person care teams include dieticians, physicians, therapists, and mentors who deliver wrap-around support to provide families progress and lasting recovery. Kristina Saffran and Erin Parks co-founded the company in San Diego, California in 2019.

Equip Health

Series A in 2021
Equip is a virtual program helping families recover from eating disorders at home with comprehensive, gold-standard care created by experts in the field and people in recovery. Equip’s five-person care teams include dieticians, physicians, therapists, and mentors who deliver wrap-around support to provide families progress and lasting recovery. Kristina Saffran and Erin Parks co-founded the company in San Diego, California in 2019.

PatientsLikeMe

Venture Round in 2021
PatientsLikeMe is a personalized health network of an integrated community, health management, and real-world data platform. It helps people find new options for treatments, connect with others, and take action to improve their outcomes. The company has worked with every major pharmaceutical company and a range of government organizations to bring the patient voice to research, development, and public policy. With more than 600,000 members, PatientsLikeMe is a trusted source for real-world disease information and a clinically robust resource that has published more than 100 research studies. The Boston, Massachusetts-located company was founded by Ben Heywood, James Heywood, and Jeff Cole in 2004

Alma

Series B in 2021
Alma is a membership-based network for mental health care providers that aims to improve access to high-quality, affordable mental health care. Its platform enables providers to accept insurance and also provides a member directory, client-matching service, scheduling, and billing functions, as well as education, training, and a community for support.

Sitka

Series A in 2021
Sitka is a customizable video software platform that connects primary care providers to the virtual specialty provider network. By upskilling primary care providers, collapsing the care cycle, and enabling patient inclusion, Sitka is transforming specialty care in the US. Founded by healthcare experts in medicine, technology, policy, and product, Sitka’s mission is to foster informed, effective and trusted care delivery for all patients by every provider. The company is backed by investors including Venrock, Optum Ventures, First Round, Rock Health, Homebrew, Lifeforce Capital, and Box Group. It was established in San Francisco, California in 2018 by Kelsey Mellard, Shaun Lindsay, and Sohrab Gollogly.

Greater Good Health

Seed Round in 2021
Greater Good Health is a healthcare organization enabling and expanding access to value-based, holistic primary care. Through an innovative Nurse Practitioner-led model, Greater Good Health partners with health plans to build primary care practices in underserved, often rural, communities, and partners with risk-bearing organizations to deploy private-labeled clinical programs that enable the shift to value-based, outcomes-focused care. Greater Good Health's proven care model and clinical programs benefit patients, providers, and payers alike, improving outcomes, reducing costs, and delivering a best-in-class patient experience.

Diameter Health

Series B in 2020
Diameter Health transforms patient information into the quantity and quality of interoperable data for healthcare organizations. The core of the Diameter Health platform is Fusion, which enables intelligent data exchange ingestion and cleansing through sophisticated normalization and cleansing processes. Data originating from any certified Electronic Health Record (EHR) is transformed into clinical information optimized for use at the point of care or to be consumed as a rich substrate for analytics.
Springtide Child Development offers personalized, holistic treatment plans for children 2-18 years old with autism and other developmental difficulties. Our interdisciplinary team of caring specialists coordinates daily to track progress and help your child succeed.

Buoy Health

Series C in 2020
Buoy provides a personalized all-in-one platform to help guide consumers back to health. Whether it's chatting about symptoms with Buoy Assistant to get help in the moment of sickness or researching benefits through Buoy Dashboard, Buoy is available 24/7 to help make self-diagnosis and navigating the healthcare system simple and easy. For employers, Buoy can be custom configured to surface benefits information and wellness programs, guide employees to in-network providers, and fully integrate with other health portals. The company was founded in 2014 and is headquartered in Boston, Massachusetts.

Truepill

Series C in 2020
Truepill is a B2B pharmacy fulfillment service. They provide a pharmacy API and fulfillment of medications to 50 states from their own facilities. They work directly with D2C consumer brands (e.g. Hims, Nurx), digital health companies, and other healthcare organizations. They are a team of 150 employees and have raised funding from Initialized Capital, Y Combinator, Slow Ventures, Sound Ventures, Tuesday Capital, Foundation Capital, Index Ventures, Social Capital, Box Group, Joe Montana, and others. Founded in 2016 by Umar Afridi and Sid Viswanathan, Truepill is headquartered in San Mateo, California.

mPulse Mobile

Series C in 2020
MPulse Mobile specializes in conversational AI and digital engagement solutions for the healthcare industry. The company combines technology, analytics, and industry expertise that helps healthcare organizations activate their customers to adopt healthy behaviors.

Lumeon

Series D in 2020
Lumeon is a digital health company that has defined the market for Care Pathway Management (CPM). From scheduling and revenue management to clinical reporting and aftercare, by looking across the end-to end care pathway, Lumeon addresses the system, and not just the symptom, behind healthcare transformation. Lumeon's customers number among Europe’s fastest growing and most innovative healthcare providers including BUPA, Nuffield Health, Alliance Medical, HCA, Optegra and Newmedica. It is headquartered in London employing over 90 people.

Truepill

Series B in 2020
Truepill is a B2B pharmacy fulfillment service. They provide a pharmacy API and fulfillment of medications to 50 states from their own facilities. They work directly with D2C consumer brands (e.g. Hims, Nurx), digital health companies, and other healthcare organizations. They are a team of 150 employees and have raised funding from Initialized Capital, Y Combinator, Slow Ventures, Sound Ventures, Tuesday Capital, Foundation Capital, Index Ventures, Social Capital, Box Group, Joe Montana, and others. Founded in 2016 by Umar Afridi and Sid Viswanathan, Truepill is headquartered in San Mateo, California.

Somatus

Series C in 2020
Somatus is a healthcare company that partners with health plans, health systems, nephrology, and primary care groups. It provides integrated care for patients with or at risk of developing kidney disease. Somatus' vertically integrated clinical services and technology delay or prevent disease progression, improve quality and care coordination, and increase the use of home dialysis modalities and rates of kidney transplantation. The company is headquartered in McLean, Virginia and is founded by a team of healthcare operators, entrepreneurs, and clinicians who treat kidney disease.

DispatchHealth

Series C in 2020
DispatchHealth is a provider of mobile and virtual healthcare for people of all ages in the comfort of their own homes. DispatchHealt was founded in 2013 and was formerly known as True North Health Navigation. It aims to create an integrated, convenient, triage, and care delivery solution that extends the capabilities of the patient's care team and provides quality care in the home while decreasing costs. It was founded in 2013 and headquartered in Denver, Colorado.

Kaia Health

Series B in 2020
Kaia Health is a digital therapeutics company that creates evidence-based treatments for a range of disorders including back pain and COPD. Working with experts in various medical fields, the company uses machine learning to deliver individualized app interventions that aim to empower and motivate patients to take control and self-manage their condition with digital alternatives from their home using devices they already own (i.e. smartphones and tablets). The company has enrolled more than 400,000 users to date in its digital therapy program. It was founded in 2016 and is headquartered in Brooklyn, New York.

DocASAP

Venture Round in 2020
DocASAP is a hospital and healthcare company that provides patient access and engagement platform for health systems, payors, and physician groups. DocASAP builds unique payer-provider connections with an eye towards simplified access, increased care compliance, and improved population risk management. DocASAP's intelligent patient-provider matching enables patients to connect with optimal care providers to enhance access, improve outcomes and reduce costs.'s The company was founded in 2012 and headquartered in Virginia, United States.

Mindstrong Health

Series C in 2020
Mindstrong is a virtual mental health platform that combines care, data and technology to help members do better, feel better & stay better. They offer mental health care with the strength to tackle anything and have helped thousands of members grow and improve their mental health— including those with serious mental illness.

Holmusk

Series A in 2020
Holmusk develops a real-world evidence platform in behavioral health and chronic diseases to expand data-driven, evidence-based care for people managing behavioral health conditions. It works by bringing together specialty behavioral health data and Holmusk’s novel analytics platform to deliver evidence-based insight that can be used to make treatment decisions, as well as the commercialization of new drugs.

LetsGetChecked

Series C in 2020
LetsGetChecked is an at-home health testing platform that connects customers to regulated laboratory testing to better manage and control one's individual health. LetsGetChecked is making healthcare and diagnostics open and patient-led, empowering people to use technology in a simple yet powerful way. This offers consumers greater control over their individual health. LetsGetChecked is headquartered in New York, New York, with tests covering general wellness, sexual health, women's health, and men's health, and is available nationwide, as well as in Canada and Europe.

Heartbeat Health

Series A in 2020
Heartbeat Health is a healthcare technology company that delivers virtual-first cardiovascular disease prevention and management. Through its data-powered platform and clinical services, the company helps patients and at-risk organizations benefit from higher-value care by reducing cardiovascular risk and the likelihood of future adverse events. It offers tools and resources critical to supporting digital care by virtually connect patients with doctors securely and helps in sharing information in real-time, and collaborate on treatment and diet consultation, and helps patients to keep track of their heart health and be in touch with a cardiologist.

RubiconMD

Series C in 2020
RubiconMD is a web-based eConsult service that enables primary care providers to quickly and easily discuss their cases with top specialists, so they can provide better care—improving the patient experience and reducing costs. RubiconMD was founded in 2013 by Gil Addo, Carlos Reines, and Julien Pham. It is headquartered in New York, New York.

Scipher Medicine

Series B in 2020
Scipher Medicine develops a healthcare platform designed to determine which drug will work best for each patient. The company is committed to transforming the way providers prescribe drugs, as well as the way manufacturers, develop new drugs. They are building a molecular map of all protein interactions that identifies genomic signatures and links those to disease and predictive treatment outcomes. Using a simple blood sample to analyze RNA, Scipher Medicine can predict if a patient is likely to respond to a targeted therapy before therapy is prescribed. This insight allows patients to start the most effective therapy from day one. For its first commercial product, they have developed PrismRA®, a first-of-its-kind blood test that can predict which patients with rheumatoid arthritis are less likely to respond to TNFi therapies such as Humira® and Enbrel® so that such patients can go on alternative approved drugs. Scipher Medicine is building the future of patient treatment. Most patients who are prescribed blockbuster therapies today don't respond to treatment, costing the healthcare industry billions in wasted drugs while patients continue to suffer. Scipher's platform identifies which drug will work based on the patient's fundamental disease biology, and not based on symptoms, disease classification, or medical bias. A routine blood test predicts which drug he/she will respond to, with our first product focusing on rheumatoid arthritis, ensuring that the most optimal treatment is prescribed from day one. The molecular data generated by our tests are then used to fuel novel target discovery to address a clear unmet medical need in patients who do not respond to any existing therapy.

Oxford VR

Series A in 2020
Oxford VR is a spin-out from Oxford University built on the work of Professor Daniel Freeman who has been developing effective VR-based mental health treatments for 15 years. Ground-breaking research, combined with the advent of highly immersive consumer VR, means that they can provide millions of treatments that are: faster and more effective than traditional treatments; significantly lower cost to health providers; loved by users. Their focus is on developing clinically validated, cost-effective, user-centered treatments for clinical conditions with significant impact on patients, the health system, and the wider economy.

Contessa

Series D in 2019
Based in Nashville, Contessa is the leader and pioneer of Home Recovery Care, a risk-based model that combines all the essential elements of inpatient hospital care in the comfort of patients’ homes. Founded in 2015, Contessa utilizes a cutting-edge proprietary health informatics platform to facilitate Home Recovery Care that is safe, affordable and improves patient outcomes. Contessa’s turnkey solution provides upfront savings to health plans, enables health systems to reinvent their care delivery model by treating patients without admitting them into the hospital, and helps physicians deliver a better experience for patients. For more information, visit contessahealth.com or follow us at @contessahealth.

Apervita

Venture Round in 2019
With wasteful healthcare spending in the U.S. estimated at $935 billion, we take our role as a healthcare innovator very seriously. Simply put, we’re on a mission to transform quality measurement and care delivery. To drive toward a Learning Health System—a framework that drives better outcomes and cost efficiencies across the health ecosystem—the industry has to commit to real change. Apervita is that change. Through our solutions and trusted collaboration platform, we’re committed to making the Learning Health System a reality, making healthcare smarter and ultimately improving patient care. As we move into our next phase of growth, we’re looking for passionate and fearless professionals to help us pursue our mission. We’ve earned the trust of our investors, including Optum Ventures, Baird Capital, Pritzker Group Venture Capital and Math Venture Partners, to further grow and scale our business. We’ve also been recognized as an industry leader by Gartner, CIOReview, Healthcare Tech Outlook, and Healthcare Informatics. Always in search of the next “first,” Apervita was named the first company to certify electronic clinical quality measures from the National Committee for Quality Assurance (NCQA) using our proprietary clinical quality language (CQL) ingestion engine. And, we were recently awarded by Healthcare Innovation for our innovative work with The Joint Commission, one of the nation’s largest regulatory organizations. We believe we’re making a difference every day to drive improvements in quality care that lead to better patient outcomes with a lower cost of care. We’re honored to be on this incredibly important journey to build a better healthcare system.

Kaia Health

Series A in 2019
Kaia Health is a digital therapeutics company that creates evidence-based treatments for a range of disorders including back pain and COPD. Working with experts in various medical fields, the company uses machine learning to deliver individualized app interventions that aim to empower and motivate patients to take control and self-manage their condition with digital alternatives from their home using devices they already own (i.e. smartphones and tablets). The company has enrolled more than 400,000 users to date in its digital therapy program. It was founded in 2016 and is headquartered in Brooklyn, New York.

Vim

Series B in 2019
Founded in 2015, Vim connects data to workflow at health care’s “last mile”: within clinical operations at the point of patient care. Health plans, patients, and medical providers of every size – from independent practitioners to integrated delivery systems – use Vim software to connect data and care across the health system. Vim’s mission is to power affordable, high quality health care through seamless connectivity. For more information, please visit getvim.com.

Buoy Health

Series B in 2019
Buoy provides a personalized all-in-one platform to help guide consumers back to health. Whether it's chatting about symptoms with Buoy Assistant to get help in the moment of sickness or researching benefits through Buoy Dashboard, Buoy is available 24/7 to help make self-diagnosis and navigating the healthcare system simple and easy. For employers, Buoy can be custom configured to surface benefits information and wellness programs, guide employees to in-network providers, and fully integrate with other health portals. The company was founded in 2014 and is headquartered in Boston, Massachusetts.

icometrix

Series A in 2019
icometrix provides clinicians with standardized measurements on their patients’ brain MRI scans in order to improve personalized care of people with a neurological disorder. icometrix was founded in 2011 by Dirk Loeckx and Wim Van Hecke. It is a spin-off company of the universities and university hospitals of Leuven and Antwerp. Today, icometrix has grown to a team of over 25 people and is internationally active, with headquarters in Leuven and an office in Boston, USA. They are the worldwide standard in MRI biomarkers in routine clinical practice. icometrix developed MSmetrix, which detects brain lesions, calculates lesion volume and measures the whole brain and grey matter volume and atrophy. MSmetrix, received market approval in the EU and other countries including Canada, Brazil and Australia. FDA clearance is pending. Furthermore, icometrix is ISO9001 and ISO13485 (Medical Devices) and ISO27001 (Information Security) certified. icometrix also acts as an image analysis expert in clinical trials and research studies. Imaging biomarkers constantly lead to new insights on neurological disorders. Since recently, imaging biomarker outcomes often serve as the primary endpoints in clinical trials for the development of new drugs. For these purposes large batches of brain imaging data are frequently transferred to icometrix for fast and high quality processing. This way our software-as-a-service is incorporated in clinical trials and large research studies regarding Traumatic Brain Injury (TBI), Epilepsy, Alzheimer’s Disease, Stroke, etc.

LetsGetChecked

Series B in 2019
LetsGetChecked is an at-home health testing platform that connects customers to regulated laboratory testing to better manage and control one's individual health. LetsGetChecked is making healthcare and diagnostics open and patient-led, empowering people to use technology in a simple yet powerful way. This offers consumers greater control over their individual health. LetsGetChecked is headquartered in New York, New York, with tests covering general wellness, sexual health, women's health, and men's health, and is available nationwide, as well as in Canada and Europe.

Diameter Health

Series A in 2019
Diameter Health transforms patient information into the quantity and quality of interoperable data for healthcare organizations. The core of the Diameter Health platform is Fusion, which enables intelligent data exchange ingestion and cleansing through sophisticated normalization and cleansing processes. Data originating from any certified Electronic Health Record (EHR) is transformed into clinical information optimized for use at the point of care or to be consumed as a rich substrate for analytics.

AbleTo

Corporate Round in 2019
AbleTo is a leading provider of virtual behavioral health care. Deep behavioral health insights and an integrated proprietary platform identifies and engages the right patients with the right support – when and how they want it. Their proven programs improve clinical outcomes and lower health care costs. AbleTo is committed to reach people with unmet behavioral health needs and eliminate barriers through virtual care. Their high-quality behavioral health care delivers results for their patients and their clients. AbleTo is proven to improve health outcomes and reduce medical costs with a program that earns high satisfaction scores from patients.

Groups Recover Together

Venture Round in 2019
Groups Recover Together was founded to make treatment for opioid addiction respectful, accessible, and affordable. We empower our members to regain control of their lives through a proven, evidence-based model of medication-assisted treatment (MAT) with buprenorphine and weekly group therapy.

Digital Diagnostics

Series A in 2018
Digital Diagnostics, formerly IDx, is a pioneering AI diagnostics company founded with a mission to transform the quality, accessibility, equity, and affordability of healthcare worldwide through the application of technology in the medical diagnosis and treatment process. Founded by Michael Abramoff, MD, PhD, a fellowship-trained retina specialist, neuroscientist, and computer engineer, Digital Diagnostics developed a patented biomarker-based approach to build an autonomous AI platform that makes clinical decisions without human intervention, removing the diagnostic burden of common diseases from specialists. Digital Diagnostics is paving the way for autonomous AI diagnosis to become the new standard of care, helping to democratize healthcare and close care gaps to improve patient outcomes. By working closely with patient advocacy groups, federal regulators, and other quality of care and ethics-focused stakeholders, Digital Diagnostics is working with the healthcare system to enable the continued adoption of autonomous AI.

Mindstrong Health

Series B in 2018
Mindstrong is a virtual mental health platform that combines care, data and technology to help members do better, feel better & stay better. They offer mental health care with the strength to tackle anything and have helped thousands of members grow and improve their mental health— including those with serious mental illness.

RubiconMD

Series B in 2018
RubiconMD is a web-based eConsult service that enables primary care providers to quickly and easily discuss their cases with top specialists, so they can provide better care—improving the patient experience and reducing costs. RubiconMD was founded in 2013 by Gil Addo, Carlos Reines, and Julien Pham. It is headquartered in New York, New York.

LetsGetChecked

Series A in 2018
LetsGetChecked is an at-home health testing platform that connects customers to regulated laboratory testing to better manage and control one's individual health. LetsGetChecked is making healthcare and diagnostics open and patient-led, empowering people to use technology in a simple yet powerful way. This offers consumers greater control over their individual health. LetsGetChecked is headquartered in New York, New York, with tests covering general wellness, sexual health, women's health, and men's health, and is available nationwide, as well as in Canada and Europe.

Apervita

Venture Round in 2017
With wasteful healthcare spending in the U.S. estimated at $935 billion, we take our role as a healthcare innovator very seriously. Simply put, we’re on a mission to transform quality measurement and care delivery. To drive toward a Learning Health System—a framework that drives better outcomes and cost efficiencies across the health ecosystem—the industry has to commit to real change. Apervita is that change. Through our solutions and trusted collaboration platform, we’re committed to making the Learning Health System a reality, making healthcare smarter and ultimately improving patient care. As we move into our next phase of growth, we’re looking for passionate and fearless professionals to help us pursue our mission. We’ve earned the trust of our investors, including Optum Ventures, Baird Capital, Pritzker Group Venture Capital and Math Venture Partners, to further grow and scale our business. We’ve also been recognized as an industry leader by Gartner, CIOReview, Healthcare Tech Outlook, and Healthcare Informatics. Always in search of the next “first,” Apervita was named the first company to certify electronic clinical quality measures from the National Committee for Quality Assurance (NCQA) using our proprietary clinical quality language (CQL) ingestion engine. And, we were recently awarded by Healthcare Innovation for our innovative work with The Joint Commission, one of the nation’s largest regulatory organizations. We believe we’re making a difference every day to drive improvements in quality care that lead to better patient outcomes with a lower cost of care. We’re honored to be on this incredibly important journey to build a better healthcare system.

Buoy Health

Series A in 2017
Buoy provides a personalized all-in-one platform to help guide consumers back to health. Whether it's chatting about symptoms with Buoy Assistant to get help in the moment of sickness or researching benefits through Buoy Dashboard, Buoy is available 24/7 to help make self-diagnosis and navigating the healthcare system simple and easy. For employers, Buoy can be custom configured to surface benefits information and wellness programs, guide employees to in-network providers, and fully integrate with other health portals. The company was founded in 2014 and is headquartered in Boston, Massachusetts.

Mindstrong Health

Series A in 2017
Mindstrong is a virtual mental health platform that combines care, data and technology to help members do better, feel better & stay better. They offer mental health care with the strength to tackle anything and have helped thousands of members grow and improve their mental health— including those with serious mental illness.

SHYFT

Series B in 2017
SHYFT Analytics, Inc. provides cloud-based data, analytics, and mobile solutions to the life sciences industry in the United States and internationally. It offers a cloud-based HTML5 mobile analytics application and data integration platform that helps life sciences companies to integrate clinical and commercial data, and translate it into patient-centric intelligence and analytics for use across functional groups to reduce cycle times across research, development, and commercialization activities. The company’s platform offers Sales solution that provides sales representatives with strategic and tactical insights, including operational alerts, patient compliance and persistency, SP scorecards, payer profiling, and more; and Specialty solution that provides pharmaceutical and biotechnology companies with integrated patient and prescriber data. Its platform also offers Launch solution that provides the market intelligence and commercial insights to support product launches; Rare Disease solution that unifies commercial and patient-centric data for stakeholder identification and management; Market Access solution that provides integrated payer analytics; and Real World Evidence (RWE), a cloud-enabled and mobile-ready solution that translates RWE data into patient-centric intelligence and guided analytics. In addition, the company offers services in the areas of launch and commercial analytics, clinical analytics and operations, insight driven design, sales strategies, and market access strategies. SHYFT Analytics, Inc. has a strategic partnership with PAREXEL International. SHYFT Analytics, Inc. was formerly known as Trinity Pharma Solutions, LLC and changed its name to SHYFT Analytics, Inc. in June 2015. The company was founded in 2002 and is based in Waltham, Massachusetts. SHYFT Analytics, Inc. operates as a subsidiary of Medidata Solutions, Inc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.